Orexin Receptor Market Value Projected to Expand by 2029
Orexin receptor market is anticipated to grow at a significant CAGR during the forecast period. Orexins are also known as hypocretins. They are two neuropeptides secreted from orexin-containing neurons, mainly in the lateral hypothalamus (LH). They play a vital regulatory role in many physiological processes such as feeding behavior, sleep–wake rhythm, reward and addiction and energy balance. The major factor driving the growth of the market is the rising prevalence of depressive disorder across the globe.
According to the National
Institute of Mental Health (NHIM), in 2019, an estimated 19.4 million adults in
the US had at least one major depressive episode which represented 7.8% of
adults. Furthermore, according to World Health Organization (WHO), depression
is a leading cause of disability globally with an estimated 3.8% of the
population affected, including 5.0% among adults and 5.7% among adults older
than 60 years in 2021. Hence, the increasing prevalence of the depressive
disorder is driving the demand for orexin receptors owing to their application
as an anti-depressant which in turn is driving the growth of the market.
Some major players in the market
include Merck & Co. Inc., GlaxoSmithKline plc, and Eisai Co., Ltd., among
others. The market players are contributing significantly to the growth of the
market by the adoption of various strategies including mergers &
acquisitions, geographical expansion, partnerships and collaborations, and new
product launches, to stay competitive in the market. For instance, in July
2020, Eisai Co., Ltd. announced the launch of its in-house-discovered and
developed orexin receptor antagonist DAYVIGO 2.5 mg, 5 mg, 10 mg tablets
(lemborexant) in Japan. It is used for the treatment of insomnia.
To Request
a Sample of our Report on Orexin Receptor Market: https://www.omrglobal.com/request-sample/orexin-receptor-market
Market Coverage
·
The market number available for – 2021-2029
·
Base year- 2021
·
Forecast period- 2023-2029
Segment Covered-
·
By Type
·
By Application
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape- Merck & Co. Inc.,
GlaxoSmithKline plc, and Eisai Co., Ltd., among others.
Orexin Receptor Market Report by Segment
By Type
·
Orexin 1 Receptor
·
Orexin 2 Receptor
By Application
·
Insomnia
·
Sleep Disorders
·
Major Depressive Disorder
·
Other
A
full Report of Orexin Receptor Market is Available @ https://www.omrglobal.com/industry-reports/orexin-receptor-market
Orexin Receptor Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment